Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment
Phase 3 Recruiting
400 enrolled
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
Phase 1 Recruiting
30 enrolled
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Recruiting
20 enrolled
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
Phase 2 Recruiting
55 enrolled
PRAGMATIC
Phase 2 Recruiting
104 enrolled
oncOPAL
Phase NA Recruiting
150 enrolled
Mind-body Medicine for Patients With Malignant Hematological Diseases
Phase NA Recruiting
94 enrolled
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Phase 2 Recruiting
30 enrolled
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Phase 1/2 Recruiting
70 enrolled
UWCCC Molecular Tumor Board Registry
Recruiting
10,000 enrolled
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Phase 1 Recruiting
50 enrolled
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Phase 2 Recruiting
46 enrolled
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Phase 1 Recruiting
60 enrolled
Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
Phase NA Recruiting
200 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 Recruiting
70 enrolled
Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Phase 3 Recruiting
218 enrolled
GVHD-PTCy
Phase 2 Recruiting
41 enrolled
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Recruiting
625 enrolled
IVIG for Infection Prevention After CAR-T-Cell Therapy
Phase 2 Recruiting
150 enrolled
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
Recruiting
15,000 enrolled
ASAP
Recruiting
25,000 enrolled
PROSPER
Recruiting
100 enrolled
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Phase NA Recruiting
160 enrolled
(HEM-FLU)
Phase 3 Recruiting
60 enrolled
Organoid
Recruiting
70 enrolled
NiCE
Phase NA Recruiting
120 enrolled
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Recruiting
38 enrolled
Role of Gut Microbiome in Cancer Therapy
Recruiting
3,000 enrolled
Early Detection of Complications During Immunotherapy for Haematological Malignancy
Phase NA Recruiting
100 enrolled
CARE-T
Phase NA Recruiting
100 enrolled
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
Phase NA Recruiting
256 enrolled
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Phase 2 Recruiting
312 enrolled
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
Recruiting
150 enrolled
Discontinuation Study
Phase NA Recruiting
70 enrolled
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Phase 1 Recruiting
20 enrolled
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
Phase 1 Recruiting
20 enrolled
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
HORIZONS
Phase NA Recruiting
350 enrolled
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Phase 2 Recruiting
15 enrolled
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Phase NA Recruiting
2,000 enrolled
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Phase 1 Recruiting
16 enrolled
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
Recruiting
170 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Phase 2 Recruiting
40 enrolled
The Impact of COVID-19 on Pulmonary Procedures
Recruiting
250 enrolled
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Recruiting
10,000 enrolled